Fairly new biotech focusing on women reproductive systems.
The is not a huge amount of on it daily and the price movement is fairly slow and consistent.
I circled the "dent" Covid put into the stock... clearly not much at all showing this beats to its own drum.
From a TA standpoint, i would really like to see this gap get filled back to at least 7.
i think a pullback down to at least $5.25 is even likely but if you set a stop loss to $5 or riskier $4.50 a 10-20% return in the next few months isnt out of the question.